Ymmunobio company logo with antibody symbol and text in blue and red on transparent background
Ymmunobio company logo with antibody symbol and text in white on transparent background
Contact

 /   News

Latest developments updates & insights

News

Latest news

Stay informed with the latest company announcements, research milestones & scientific publications from Ymmunobio.

All news

Portrait of Martin Zuzulo, Chief Operating Officer at Ymmunobio

Ymmunobio Appoints New Chief Operating Officer

Swiss Confederation emblem representing Innosuisse, Switzerland’s Innovation Agency supporting startups

Ymmunobio Accepted into Innosuisse Core Coaching

Dr. Mitsuro Kanda and Dr. Vishal Khairnar join Ymmunobio Advisory Board to advance antibody-based cancer research

Ymmunobio Welcomes Dr. Kanda and Dr. Khairnar to Advisory Board

Close-up of stacked newspapers used as background image for Ymmunobio news and publication posts

FDA Grants Orphan Drug Designation to Ymmunobio’s CEACAM Antibody for the Treatment of Liver Cancer

Dr. Caroline Germa, MD, Clinical Oncology Development Expert and Board Member at Ymmunobio

Ymmunobio Appoints Dr. Caroline Germa to Board of Directors

Close-up of stacked newspapers used as background image for Ymmunobio news and publication posts

Ymmunobio Appoints Angela S. Gibbs as Chief Business Officer